Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

449 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-09-30

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is conducted in the United States of America (USA). Tha aim of this study is bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

NCT02396862

Hemophilia A

COMPLETED

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

NCT02053792

Hemophilia B

COMPLETED PHASE3

Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia

NCT01988532

Congenital Bleeding Disorder Haemophilia A Haemophilia A With Inhibitors +2 more

COMPLETED

Bleeding Symptoms of Carriers of Hemophilia A and B

NCT01029808

Hemophilia

COMPLETED

Survey Evaluating the Psychosocial Effects of Living With Haemophilia

NCT01322620

Congenital Bleeding Disorder Haemophilia A Haemophilia B +3 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Haemostasis Congenital Bleeding Disorder Haemophilia B

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Survey

No treatment given

Intervention Type OTHER

This is an online web-based cross-sectional survey in which participants will complete one of two questionnaires.

There will be no treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No treatment given

This is an online web-based cross-sectional survey in which participants will complete one of two questionnaires.

There will be no treatment.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged below or equal to 18 years with hemophilia B (any severity, with or without inhibitors)
* Caregivers of children currently aged below 18 years with hemophilia B (any severity, with or without inhibitors)
* Subjects must have access to the internet, either at home or at a location convenient to them
* Provision of informed consent before the start of any survey-related activities

Exclusion Criteria

* Inability to understand and comply with written instructions in English
* Previous completion of the B-HERO-S study with receipt of compensation
* Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No